+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

POCT Market in Europe 2023-2027

  • PDF Icon

    Report

  • 162 Pages
  • July 2023
  • Region: Europe
  • TechNavio
  • ID: 5868256
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The POCT market in Europe is forecasted to grow by USD 5,750.84 mn during 2022-2027, accelerating at a CAGR of 7.75% during the forecast period. The report on the POCT market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increased focus on personalized medicine, and growing adoption of automated diagnostic devices in healthcare industry.

The POCT market in Europe is segmented as below:

By Type

  • OTC testing
  • Prescription-based testing

By Application

  • Blood glucose testing
  • Infectious diseases testing
  • Cardiac markers testing
  • Pregnancy and fertility testing
  • Others

By Geographical Landscape

  • Europe
This study identifies the shift from conventional testing methods to rapid diagnostic test as one of the prime reasons driving the POCT market in Europe growth during the next few years. Also, technological advances in diagnostics and increasing focus on introducing low-cost test strips will lead to sizable demand in the market.

The report on the POCT market in Europe covers the following areas:

  • POCT market sizing in Europe
  • POCT market forecast in Europe
  • POCT market industry analysis in Europe
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POCT market in Europe vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Fluxergy Inc., Johnson and Johnson Services Inc., LifeScan IP Holdings LLC, Nova Biomedical Corp., OraSure Technologies Inc., PHC Holdings Corp., Sd Biosensor Inc., Siemens AG, Sinocare Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc. Also, the POCT market in Europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Europe: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
4 Historic Market Size
4.1 POCT market in Europe 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on poct market in Europe 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 22: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 25: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 26: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 27: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 28: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 29: Chart on Type - Market share 2022-2027 (%)
Exhibit 30: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 31: Chart on Comparison by Type
Exhibit 32: Data Table on Comparison by Type
6.3 OTC testing - Market size and forecast 2022-2027
Exhibit 33: Chart on OTC testing - Market size and forecast 2022-2027 ($ million)
Exhibit 34: Data Table on OTC testing - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Chart on OTC testing - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on OTC testing - Year-over-year growth 2022-2027 (%)
6.4 Prescription-based testing - Market size and forecast 2022-2027
Exhibit 37: Chart on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
Exhibit 38: Data Table on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Chart on Prescription-based testing - Year-over-year growth 2022-2027 (%)
Exhibit 40: Data Table on Prescription-based testing - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 41: Market opportunity by Type ($ million)
Exhibit 42: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 43: Chart on Application - Market share 2022-2027 (%)
Exhibit 44: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 45: Chart on Comparison by Application
Exhibit 46: Data Table on Comparison by Application
7.3 Blood glucose testing - Market size and forecast 2022-2027
Exhibit 47: Chart on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Blood glucose testing - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Blood glucose testing - Year-over-year growth 2022-2027 (%)
7.4 Infectious diseases testing - Market size and forecast 2022-2027
Exhibit 51: Chart on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
7.5 Cardiac markers testing - Market size and forecast 2022-2027
Exhibit 55: Chart on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
7.6 Pregnancy and fertility testing - Market size and forecast 2022-2027
Exhibit 59: Chart on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
7.7 Others - Market size and forecast 2022-2027
Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Application
Exhibit 67: Market opportunity by Application ($ million)
Exhibit 68: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 70: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibit 71: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
9.2 Geographic comparison
Exhibit 72: Chart on Geographic comparison
Exhibit 73: Data Table on Geographic comparison
9.3 Germany - Market size and forecast 2022-2027
Exhibit 74: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.4 France - Market size and forecast 2022-2027
Exhibit 78: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 81: Data Table on France - Year-over-year growth 2022-2027 (%)
9.5 Italy - Market size and forecast 2022-2027
Exhibit 82: Chart on Italy - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Chart on Italy - Year-over-year growth 2022-2027 (%)
Exhibit 85: Data Table on Italy - Year-over-year growth 2022-2027 (%)
9.6 UK - Market size and forecast 2022-2027
Exhibit 86: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 89: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.7 Rest of Europe - Market size and forecast 2022-2027
Exhibit 90: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibit 93: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
9.8 Market opportunity By Geographical Landscape
Exhibit 94: Market opportunity By Geographical Landscape ($ million)
Exhibit 95: Data Table on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 96: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 97: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 98: Overview on factors of disruption
11.4 Industry risks
Exhibit 99: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 100: Vendors covered
12.2 Market positioning of vendors
Exhibit 101: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 102: Abbott Laboratories - Overview
Exhibit 103: Abbott Laboratories - Business segments
Exhibit 104: Abbott Laboratories - Key news
Exhibit 105: Abbott Laboratories - Key offerings
Exhibit 106: Abbott Laboratories - Segment focus
12.4 Becton Dickinson and Co.
Exhibit 107: Becton Dickinson and Co. - Overview
Exhibit 108: Becton Dickinson and Co. - Business segments
Exhibit 109: Becton Dickinson and Co. - Key news
Exhibit 110: Becton Dickinson and Co. - Key offerings
Exhibit 111: Becton Dickinson and Co. - Segment focus
12.5 bioMerieux SA
Exhibit 112: bioMerieux SA - Overview
Exhibit 113: bioMerieux SA - Product/Service
Exhibit 114: bioMerieux SA - Key offerings
12.6 Danaher Corp.
Exhibit 115: Danaher Corp. - Overview
Exhibit 116: Danaher Corp. - Business segments
Exhibit 117: Danaher Corp. - Key news
Exhibit 118: Danaher Corp. - Key offerings
Exhibit 119: Danaher Corp. - Segment focus
12.7 F. Hoffmann La Roche Ltd.
Exhibit 120: F. Hoffmann La Roche Ltd. - Overview
Exhibit 121: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 122: F. Hoffmann La Roche Ltd. - Key news
Exhibit 123: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 124: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Fluxergy Inc.
Exhibit 125: Fluxergy Inc. - Overview
Exhibit 126: Fluxergy Inc. - Product/Service
Exhibit 127: Fluxergy Inc. - Key offerings
12.9 Johnson and Johnson Services Inc.
Exhibit 128: Johnson and Johnson Services Inc. - Overview
Exhibit 129: Johnson and Johnson Services Inc. - Business segments
Exhibit 130: Johnson and Johnson Services Inc. - Key news
Exhibit 131: Johnson and Johnson Services Inc. - Key offerings
Exhibit 132: Johnson and Johnson Services Inc. - Segment focus
12.10 LifeScan IP Holdings LLC
Exhibit 133: LifeScan IP Holdings LLC - Overview
Exhibit 134: LifeScan IP Holdings LLC - Product/Service
Exhibit 135: LifeScan IP Holdings LLC - Key offerings
12.11 Nova Biomedical Corp.
Exhibit 136: Nova Biomedical Corp. - Overview
Exhibit 137: Nova Biomedical Corp. - Product/Service
Exhibit 138: Nova Biomedical Corp. - Key offerings
12.12 PHC Holdings Corp.
Exhibit 139: PHC Holdings Corp. - Overview
Exhibit 140: PHC Holdings Corp. - Business segments
Exhibit 141: PHC Holdings Corp. - Key offerings
Exhibit 142: PHC Holdings Corp. - Segment focus
12.13 Siemens AG
Exhibit 143: Siemens AG - Overview
Exhibit 144: Siemens AG - Business segments
Exhibit 145: Siemens AG - Key news
Exhibit 146: Siemens AG - Key offerings
Exhibit 147: Siemens AG - Segment focus
12.14 Sinocare Inc.
Exhibit 148: Sinocare Inc. - Overview
Exhibit 149: Sinocare Inc. - Product/Service
Exhibit 150: Sinocare Inc. - Key news
Exhibit 151: Sinocare Inc. - Key offerings
12.15 Sysmex Corp.
Exhibit 152: Sysmex Corp. - Overview
Exhibit 153: Sysmex Corp. - Business segments
Exhibit 154: Sysmex Corp. - Key offerings
Exhibit 155: Sysmex Corp. - Segment focus
12.16 Thermo Fisher Scientific Inc.
Exhibit 156: Thermo Fisher Scientific Inc. - Overview
Exhibit 157: Thermo Fisher Scientific Inc. - Business segments
Exhibit 158: Thermo Fisher Scientific Inc. - Key news
Exhibit 159: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 160: Thermo Fisher Scientific Inc. - Segment focus
12.17 Trinity Biotech Plc
Exhibit 161: Trinity Biotech Plc - Overview
Exhibit 162: Trinity Biotech Plc - Product/Service
Exhibit 163: Trinity Biotech Plc - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 164: Inclusions checklist
Exhibit 165: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 166: Currency conversion rates for US$
13.4 Research methodology
Exhibit 167: Research methodology
Exhibit 168: Validation techniques employed for market sizing
Exhibit 169: Information sources
13.5 List of abbreviations
Exhibit 170: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Europe: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
Exhibits 18: Historic Market Size - Data Table on poct market in Europe 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Five forces analysis - Comparison between 2022 and 2027
Exhibits 23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 25: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 28: Chart on Market condition - Five forces 2022 and 2027
Exhibits 29: Chart on Type - Market share 2022-2027 (%)
Exhibits 30: Data Table on Type - Market share 2022-2027 (%)
Exhibits 31: Chart on Comparison by Type
Exhibits 32: Data Table on Comparison by Type
Exhibits 33: Chart on OTC testing - Market size and forecast 2022-2027 ($ million)
Exhibits 34: Data Table on OTC testing - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Chart on OTC testing - Year-over-year growth 2022-2027 (%)
Exhibits 36: Data Table on OTC testing - Year-over-year growth 2022-2027 (%)
Exhibits 37: Chart on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
Exhibits 38: Data Table on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Chart on Prescription-based testing - Year-over-year growth 2022-2027 (%)
Exhibits 40: Data Table on Prescription-based testing - Year-over-year growth 2022-2027 (%)
Exhibits 41: Market opportunity by Type ($ million)
Exhibits 42: Data Table on Market opportunity by Type ($ million)
Exhibits 43: Chart on Application - Market share 2022-2027 (%)
Exhibits 44: Data Table on Application - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Application
Exhibits 46: Data Table on Comparison by Application
Exhibits 47: Chart on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Blood glucose testing - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Blood glucose testing - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
Exhibits 59: Chart on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
Exhibits 60: Data Table on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Chart on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
Exhibits 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 67: Market opportunity by Application ($ million)
Exhibits 68: Data Table on Market opportunity by Application ($ million)
Exhibits 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 70: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits 71: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits 72: Chart on Geographic comparison
Exhibits 73: Data Table on Geographic comparison
Exhibits 74: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 77: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 78: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 81: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 82: Chart on Italy - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Chart on Italy - Year-over-year growth 2022-2027 (%)
Exhibits 85: Data Table on Italy - Year-over-year growth 2022-2027 (%)
Exhibits 86: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 89: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 90: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibits 93: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibits 94: Market opportunity By Geographical Landscape ($ million)
Exhibits 95: Data Table on Market opportunity By Geographical Landscape ($ million)
Exhibits 96: Impact of drivers and challenges in 2022 and 2027
Exhibits 97: Overview on Criticality of inputs and Factors of differentiation
Exhibits 98: Overview on factors of disruption
Exhibits 99: Impact of key risks on business
Exhibits 100: Vendors covered
Exhibits 101: Matrix on vendor position and classification
Exhibits 102: Abbott Laboratories - Overview
Exhibits 103: Abbott Laboratories - Business segments
Exhibits 104: Abbott Laboratories - Key news
Exhibits 105: Abbott Laboratories - Key offerings
Exhibits 106: Abbott Laboratories - Segment focus
Exhibits 107: Becton Dickinson and Co. - Overview
Exhibits 108: Becton Dickinson and Co. - Business segments
Exhibits 109: Becton Dickinson and Co. - Key news
Exhibits 110: Becton Dickinson and Co. - Key offerings
Exhibits 111: Becton Dickinson and Co. - Segment focus
Exhibits 112: bioMerieux SA - Overview
Exhibits 113: bioMerieux SA - Product/Service
Exhibits 114: bioMerieux SA - Key offerings
Exhibits 115: Danaher Corp. - Overview
Exhibits 116: Danaher Corp. - Business segments
Exhibits 117: Danaher Corp. - Key news
Exhibits 118: Danaher Corp. - Key offerings
Exhibits 119: Danaher Corp. - Segment focus
Exhibits 120: F. Hoffmann La Roche Ltd. - Overview
Exhibits 121: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 122: F. Hoffmann La Roche Ltd. - Key news
Exhibits 123: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 124: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 125: Fluxergy Inc. - Overview
Exhibits 126: Fluxergy Inc. - Product/Service
Exhibits 127: Fluxergy Inc. - Key offerings
Exhibits 128: Johnson and Johnson Services Inc. - Overview
Exhibits 129: Johnson and Johnson Services Inc. - Business segments
Exhibits 130: Johnson and Johnson Services Inc. - Key news
Exhibits 131: Johnson and Johnson Services Inc. - Key offerings
Exhibits 132: Johnson and Johnson Services Inc. - Segment focus
Exhibits 133: LifeScan IP Holdings LLC - Overview
Exhibits 134: LifeScan IP Holdings LLC - Product/Service
Exhibits 135: LifeScan IP Holdings LLC - Key offerings
Exhibits 136: Nova Biomedical Corp. - Overview
Exhibits 137: Nova Biomedical Corp. - Product/Service
Exhibits 138: Nova Biomedical Corp. - Key offerings
Exhibits 139: PHC Holdings Corp. - Overview
Exhibits 140: PHC Holdings Corp. - Business segments
Exhibits 141: PHC Holdings Corp. - Key offerings
Exhibits 142: PHC Holdings Corp. - Segment focus
Exhibits 143: Siemens AG - Overview
Exhibits 144: Siemens AG - Business segments
Exhibits 145: Siemens AG - Key news
Exhibits 146: Siemens AG - Key offerings
Exhibits 147: Siemens AG - Segment focus
Exhibits 148: Sinocare Inc. - Overview
Exhibits 149: Sinocare Inc. - Product/Service
Exhibits 150: Sinocare Inc. - Key news
Exhibits 151: Sinocare Inc. - Key offerings
Exhibits 152: Sysmex Corp. - Overview
Exhibits 153: Sysmex Corp. - Business segments
Exhibits 154: Sysmex Corp. - Key offerings
Exhibits 155: Sysmex Corp. - Segment focus
Exhibits 156: Thermo Fisher Scientific Inc. - Overview
Exhibits 157: Thermo Fisher Scientific Inc. - Business segments
Exhibits 158: Thermo Fisher Scientific Inc. - Key news
Exhibits 159: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 160: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 161: Trinity Biotech Plc - Overview
Exhibits 162: Trinity Biotech Plc - Product/Service
Exhibits 163: Trinity Biotech Plc - Key offerings
Exhibits 164: Inclusions checklist
Exhibits 165: Exclusions checklist
Exhibits 166: Currency conversion rates for US$
Exhibits 167: Research methodology
Exhibits 168: Validation techniques employed for market sizing
Exhibits 169: Information sources
Exhibits 170: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global poct market in Europe: A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Fluxergy Inc., Johnson and Johnson Services Inc., LifeScan IP Holdings LLC, Nova Biomedical Corp., OraSure Technologies Inc., PHC Holdings Corp., Sd Biosensor Inc., Siemens AG, Sinocare Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is shift from conventional testing methods to rapid diagnostic test.'

According to the report, one of the major drivers for this market is the growing geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Becton Dickinson and Co.
  • bioMerieux SA
  • Chembio Diagnostics Inc.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Fluxergy Inc.
  • Johnson and Johnson Services Inc.
  • LifeScan IP Holdings LLC
  • Nova Biomedical Corp.
  • OraSure Technologies Inc.
  • PHC Holdings Corp.
  • Sd Biosensor Inc.
  • Siemens AG
  • Sinocare Inc.
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc

Related Topics

Related Reports

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Trends, Recent Developments, Company Profiles - Forecast to 2030 - Product Image

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Trends, Recent Developments, Company Profiles - Forecast to 2030

  • Report
  • 303 Pages
  • Global
From
Point of Care Testing (POCT) Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Point of Care Testing (POCT) Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 113 Pages
  • Global
From
Global Point of Care Testing Market by Product (Cardio-Metabolic Monitoring Kits, Cholesterol Test Strips, Fertility & Pregnancy Testing Kits), End-User (Ambulatory Care, Home Care, Hospitals or Critical Care) - Forecast 2024-2030 - Product Image

Global Point of Care Testing Market by Product (Cardio-Metabolic Monitoring Kits, Cholesterol Test Strips, Fertility & Pregnancy Testing Kits), End-User (Ambulatory Care, Home Care, Hospitals or Critical Care) - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
2024 Global Forecast for Point-Of-Care (Poc) Testing (Poct) Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Point-Of-Care (Poc) Testing (Poct) Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
2024 POCT Forecasts for 300 Assays, 2023 Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers - Product Image

2024 POCT Forecasts for 300 Assays, 2023 Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers

  • Report
  • Global
From

About the POCT Market

Point-of-Care Diagnostics (POCT) is a type of medical testing that is performed at or near the site of patient care. This type of testing is used to provide rapid results to clinicians, allowing them to make timely decisions about patient care. POCT is used in a variety of settings, including hospitals, clinics, and other healthcare facilities. It is also used in home settings, allowing patients to monitor their own health. POCT is used to diagnose a wide range of conditions, including infectious diseases, cardiovascular diseases, and metabolic disorders. It is also used to monitor the effectiveness of treatments and to detect drug abuse. POCT is becoming increasingly popular due to its convenience and cost-effectiveness. Some companies in the POCT market include Abbott, Roche, Siemens, Alere, and Becton Dickinson. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.